Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 102

    1.

    Human APOBEC1 cytidine deaminase edits HBV DNA.

    Gonzalez MC, Suspène R, Henry M, Guétard D, Wain-Hobson S, Vartanian JP.

    Retrovirology. 2009 Oct 21;6:96.

    PMID:
    19843348
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    2.

    Massive APOBEC3 editing of hepatitis B viral DNA in cirrhosis.

    Vartanian JP, Henry M, Marchio A, Suspène R, Aynaud MM, Guétard D, Cervantes-Gonzalez M, Battiston C, Mazzaferro V, Pineau P, Dejean A, Wain-Hobson S.

    PLoS Pathog. 2010 May 27;6(5):e1000928.

    PMID:
    20523896
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    3.

    Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo.

    Suspène R, Guétard D, Henry M, Sommer P, Wain-Hobson S, Vartanian JP.

    Proc Natl Acad Sci U S A. 2005 Jun 7;102(23):8321-6. Epub 2005 May 26.

    PMID:
    15919829
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    4.

    APOBEC1 and APOBEC3 cytidine deaminases as restriction factors for hepadnaviral genomes in non-humans in vivo.

    Renard M, Henry M, Guétard D, Vartanian JP, Wain-Hobson S.

    J Mol Biol. 2010 Jul 16;400(3):323-34. Epub 2010 May 28.

    PMID:
    20546753
    [PubMed - indexed for MEDLINE]
    5.

    Genetic editing of HBV DNA by monodomain human APOBEC3 cytidine deaminases and the recombinant nature of APOBEC3G.

    Henry M, Guétard D, Suspène R, Rusniok C, Wain-Hobson S, Vartanian JP.

    PLoS One. 2009;4(1):e4277. Epub 2009 Jan 26.

    PMID:
    19169351
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    6.

    Murine APOBEC1 is a powerful mutator of retroviral and cellular RNA in vitro and in vivo.

    Petit V, Guétard D, Renard M, Keriel A, Sitbon M, Wain-Hobson S, Vartanian JP.

    J Mol Biol. 2009 Jan 9;385(1):65-78. Epub 2008 Nov 1.

    PMID:
    18983852
    [PubMed - indexed for MEDLINE]
    7.

    Hepatitis B virus DNA is subject to extensive editing by the human deaminase APOBEC3C.

    Baumert TF, Rösler C, Malim MH, von Weizsäcker F.

    Hepatology. 2007 Sep;46(3):682-9.

    PMID:
    17625792
    [PubMed - indexed for MEDLINE]
    8.

    Hepatitis B: modern concepts in pathogenesis--APOBEC3 cytidine deaminases as effectors in innate immunity against the hepatitis B virus.

    Bonvin M, Greeve J.

    Curr Opin Infect Dis. 2008 Jun;21(3):298-303. Review.

    PMID:
    18448976
    [PubMed - indexed for MEDLINE]
    9.

    Interferon-inducible expression of APOBEC3 editing enzymes in human hepatocytes and inhibition of hepatitis B virus replication.

    Bonvin M, Achermann F, Greeve I, Stroka D, Keogh A, Inderbitzin D, Candinas D, Sommer P, Wain-Hobson S, Vartanian JP, Greeve J.

    Hepatology. 2006 Jun;43(6):1364-74.

    PMID:
    16729314
    [PubMed - indexed for MEDLINE]
    11.

    Final Report on Carcinogens Background Document for Styrene.

    National Toxicology Program.

    Rep Carcinog Backgr Doc. 2008 Sep;(8-5978):i-398.

    PMID:
    20737009
    [PubMed - as supplied by publisher]
    12.

    APOBEC-mediated interference with hepadnavirus production.

    Rösler C, Köck J, Kann M, Malim MH, Blum HE, Baumert TF, von Weizsäcker F.

    Hepatology. 2005 Aug;42(2):301-9.

    PMID:
    16025511
    [PubMed - indexed for MEDLINE]
    13.

    N-terminal and C-terminal cytosine deaminase domain of APOBEC3G inhibit hepatitis B virus replication.

    Lei YC, Tian YJ, Ding HH, Wang BJ, Yang Y, Hao YH, Zhao XP, Lu MJ, Gong FL, Yang DL.

    World J Gastroenterol. 2006 Dec 14;12(46):7488-96.

    PMID:
    17167839
    [PubMed - indexed for MEDLINE]
    Free Article
    14.

    Hypermutation of hepatitis B virus genomes by APOBEC3G, APOBEC3C and APOBEC3H.

    Köck J, Blum HE.

    J Gen Virol. 2008 May;89(Pt 5):1184-91.

    PMID:
    18420796
    [PubMed - indexed for MEDLINE]
    Free Article
    15.

    Final Report on Carcinogens Background Document for Formaldehyde.

    National Toxicology Program.

    Rep Carcinog Backgr Doc. 2010 Jan;(10-5981):i-512.

    PMID:
    20737003
    [PubMed - as supplied by publisher]
    16.

    Deamination-independent inhibition of hepatitis B virus reverse transcription by APOBEC3G.

    Nguyen DH, Gummuluru S, Hu J.

    J Virol. 2007 May;81(9):4465-72. Epub 2007 Feb 21.

    PMID:
    17314171
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    17.

    Association of human APOBEC3 cytidine deaminases with the generation of hepatitis virus B x antigen mutants and hepatocellular carcinoma.

    Xu R, Zhang X, Zhang W, Fang Y, Zheng S, Yu XF.

    Hepatology. 2007 Dec;46(6):1810-20.

    PMID:
    17847074
    [PubMed - indexed for MEDLINE]
    18.

    APOBEC3-independent interferon-induced viral clearance in hepatitis B virus transgenic mice.

    Turelli P, Liagre-Quazzola A, Mangeat B, Verp S, Jost S, Trono D.

    J Virol. 2008 Jul;82(13):6585-90. Epub 2008 Apr 23.

    PMID:
    18434399
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    19.

    Extensive editing of a small fraction of human T-cell leukemia virus type 1 genomes by four APOBEC3 cytidine deaminases.

    Mahieux R, Suspène R, Delebecque F, Henry M, Schwartz O, Wain-Hobson S, Vartanian JP.

    J Gen Virol. 2005 Sep;86(Pt 9):2489-94.

    PMID:
    16099907
    [PubMed - indexed for MEDLINE]
    Free Article
    20.

    Cytidine deaminase APOBEC3B interacts with heterogeneous nuclear ribonucleoprotein K and suppresses hepatitis B virus expression.

    Zhang W, Zhang X, Tian C, Wang T, Sarkis PT, Fang Y, Zheng S, Yu XF, Xu R.

    Cell Microbiol. 2008 Jan;10(1):112-21. Epub 2007 Aug 1.

    PMID:
    17672864
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk